| Date | Title | Description |
| 16.09.2026 | Top Tech News Today, September 16, 2026: Google, Isomorphic Labs, Meta, Nvidia, OpenAI & More | It’s Wednesday, September 16, 2026, and the tech industry is talking out of both sides of its mouth. OpenAI is shopping a valuation as high as $1.5 trillion while postponing an IPO on safety grounds. Nvidia and Meta say new rules are unnece... |
| 08.09.2026 | Boss of San Francisco-based AI coding startup pokes fun at “monoculture” Silicon Valley, as opens London office | The boss of US AI coding startup Replit yesterday said it could hire up to 100 staff in London by early next year, as it opened its first overseas office in the capital.
Amjad Masad, co-founder and CEO of San Francisco-headquartered Replit,... |
| 06.08.2026 | Top Tech News Today, August 6, 2026: Google, Meta, OpenAI, Robinhood, SpaceX, Tencent, Unitree & More | It’s Thursday, August 6, 2026, and the tech world just hit a rare triple pulse: AI models from Meta and OpenAI slipped containment during security tests and started rewriting systems they were never meant to touch, Google DeepMind tore up i... |
| 06.08.2026 | The UK's top-funded tech companies in H1 2026 | According to Tech.eu's H1 2026 report, the UK remained Europe's largest technology funding market in the first half of 2026, raising €18.7 billion across 423 deals. Capital was concentrated in a limited number of large transactions, with cl... |
| 06.08.2026 | Google is expanding its AI empire — and losing the people who built it | Google’s cloud boom is testing the company’s commitment to frontier AI as commercial returns take priority.
Jeff Dean’s departure and Demis Hassabis’ move away from daily management of DeepMind add to questions about Google’s ability to ret... |
| 05.08.2026 | Demis Hassabis steps down as Google DeepMind CEO to become Alphabet chief scientist and focus on AGI | Demis Hassabis is stepping away from day-to-day leadership of Google DeepMind to become chairman of the AI lab and chief scientist of Alphabet, a sweeping leadership change that comes with an extraordinary explanation from the DeepMind co-f... |
| 30.07.2026 | More capital. Fewer deals. What H1 2026 tells us about European tech | Throughout the year we track various data points across the European tech ecosystem, and the mid-year mark is a great time to review numbers and highlight significant milestones and what the implications might be, as well as identify trends... |
| 30.07.2026 | CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise | What You Should Know
The latest CB Insights report, Q2 2026 State of Digital Health reveals global digital health deal activity reached a decade-low of 228 deals in Q2 2026, marking a 36% decline quarter-over-quarter and a two-thirds drop f... |
| 29.07.2026 | ustwo brings AI governance to the boardroom with appointment of Google DeepMind executive Simon Bouton | ustwo, the global employee-owned B Corp digital product studio, today announced the appointment of Simon Bouton, Chief Experience Officer at Google DeepMind, as its first AI Non-Executive Director.
This press release features multimedia. Vi... |
| 17.07.2026 | UK AI Funding Reaches Record £4.56BN in “Landmark” Quarter | AI firms in the UK raised a record £4.56 billion in equity funding in the second quarter fo 2026, accounting for 57% of all equity investment in the country, according to new data from Beauhurst.
Acorss the 1,070 equity deals in all UK sect... |
| 15.06.2026 | May 2026's top 10 European tech deals you need to know about | European tech activity in May 2026 was characterised by a decline in deal volume but a substantial increase in capital raised compared to April. The ecosystem recorded 258 funding deals and €10.5 billion raised, compared to 290 deals and €5... |
| 09.06.2026 | Liz Kendall hails ‘Brit-maxxing’ as Labour bets £1.1bn on AI chip race | Britain must stop listening to the “doubters, doom-mongers and naysayers” and double down on its strengths in AI, Liz Kendall said as she unveiled a £1.1bn package aimed to turn the UK into a global AI hardware powerhouse.
Addressing London... |
| 09.06.2026 | FinSMEs Intelligence Releases May 2026 Global Venture Capital Report: 454 Deals Mapped with AI and Enterprise Software Dominating | LONDON, UK — June 9, 2026 — FinSMEs Intelligence, the structured data-intelligence arm of FinSMEs.com, has officially released its Global Venture Capital Activity Report for May 2026.
The comprehensive dataset, which programmatically tracke... |
| 01.06.2026 | Sadiq Khan: London tech boom can weather ‘dizzying’ AI risks | Sadiq Khan has insisted London is “busy writing” the future of AI despite the “dizzying” risks posed by the technology, as fresh figures show the capital has reclaimed its position as Europe’s leading tech hub.
The Mayor of London said AI p... |
| 28.05.2026 | London reclaims European tech crown as money floods into AI and fintech | London has reclaimed its position as Europe’s leading tech spot, overtaking Paris after a sharp rise in AI investment and a renewed influx of global capital into its startup scene.
New figures from Dealroom show London ranked fourth globall... |
| 19.05.2026 | Fractile Fuels AI Leap with $220M for Next-Gen Inference Chips | Fractile secured $220M in Series B funding to revolutionize AI inference hardware. The UK-based startup engineers chips that dramatically accelerate AI output generation. Current systems generate about 40 tokens per second, making complex t... |
| 18.05.2026 | Barclays names Fractile and Isomorphic Labs among UK’s top AI startups | Barclays has named AI chip startup Fractile and Google DeepMind spinout Isomorphic Labs among Britain’s top AI companies as investors race to back the next generation of UK tech champions.
The banking giant’s Eagle Labs division unveiled it... |
| 15.05.2026 | Isomorphic Labs lands $2.1B, Keel's post-neobank pivot, and Poland's software evolution | This week, we tracked more than 55 tech funding deals worth over €4 billion and over 10 exits, M&A transactions, rumours, and related news stories across Europe.
If email is more your thing, you can always subscribe to our newsletter an... |
| 13.05.2026 | Isomorphic Labs Secures $2.1 Billion for AI Drug Discovery Global Scale | Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital injection accelerates its world-leading AI drug design engine, IsoDDE. The company expands globally, fast-tracking its therapeutic pipeline. Isomorphic aims to... |
| 13.05.2026 | Fractile lands $220m as ministers hail ‘vote of confidence’ in UK AI | British AI chip startup Fractile has raised $220m (£165m) in fresh funding with the government pointing to the deal as evidence the UK can produce globally competitive AI infrastructure companies.
The London-founded company, which is develo... |
| 13.05.2026 | Isomorphic Labs Wins Latest Investment from Sovereign AI Fund | Isomorphic Labs, a London-founded and headquartered company, using AI to design and develop new medicines, has been named as the latest firm to receive investment from the UK Government’s Sovereign AI Fund.
The investment forms part of a fu... |
| 13.05.2026 | Isomorphic Labs Raises $2.1 Billion Series B To Scale AI Drug Design Engine And Advance Therapeutic Pipeline | Isomorphic Labs, the London-based AI-first drug design and development company, has raised $2.1 billion in Series B funding to accelerate its evolution from pioneering novel AI models to applying them at scale. The round is led by Thrive Ca... |
| 13.05.2026 | DeepMind CEO Demis Hassabisâ Isomorphic Labs raises $2.1 billion led by Thrive Capital | Synopsis
AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of their AI drug design engine and advance therapeutic candidates. The investment underscores st... |
| 13.05.2026 | Isomorphic Labs lands $2.1BN investment | Sir Demis Hassabis has hailed a multi-billion-dollar investment in the startup he founded which was spun out of Google DeepMind and focuses on leveraging AI to help drug discovery as a “massive vote of confidence”.
Isomorphic Labs said it h... |
| 13.05.2026 | Anthropic in talks to raise $30 billion at $900 billion valuation | Synopsis
AI firm Anthropic is in early talks to raise over thirty billion dollars. The company seeks a valuation exceeding nine hundred billion dollars. This funding aims to support its growing AI software demand. The deal could close by mo... |
| 12.05.2026 | Isomorphic Labs Raises $2.1B for AI Drug Discovery | Isomorphic Labs, a startup that had a declaration of backing from Google DeepMind, has raised $2.1 billion in a Series B funding round. The large investment, which is one of the biggest rounds ever in the “AI bio” space, highlights the incr... |
| 12.05.2026 | Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine | Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.
LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and d... |
| 12.05.2026 | Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery | May 12 : Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive Capital.
The funding round, completed at an undiscl... |
| 12.05.2026 | Isomorphic Labs Raises $2.1 Billion in Series B Funding | Isomorphic Labs, a London, United Kingdom-based developer of an AI-first drug design and development platform, raised $2.1 billion in Series B funding.
The round was led by Thrive Capital, with participation from Alphabet, GV, MGX, Temasek,... |
| 12.05.2026 | Alphabet-backed Isomorphic Labs raises $2.1B to accelerate AI-designed drug discovery as clinical trials near | Drug discovery has long been one of the slowest and most expensive parts of modern medicine. Isomorphic Labs, a drug discovery startup spun out of Google DeepMind, wants artificial intelligence to change that, and investors are betting bill... |
| 09.05.2026 | Googleâs Isomorphic Labs to raise over $2 billion in new funding | Synopsis
Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. This significant investment aims to bolster its drug design engine and fuel global expansion... |
| 08.05.2026 | Alphabet’s Isomorphic Labs reportedly raising $2B+ for its medical research AI | Isomorphic Labs Inc., an Alphabet Inc. unit using artificial intelligence to speed up drug development, is reportedly in talks to raise a new funding round.
Sources told Bloomberg today that the investment could be worth more than $2 billio... |
| 07.05.2026 | Healthtech: 10 companies that raised the most in 2025 | In 2025, Europe’s healthtech ecosystem showed strong funding momentum, with capital concentrated in large rounds across biotech, medtech, digital health, and AI-enabled healthcare. The biggest deals came from companies such as Oura Health, ... |
| 12.03.2026 | 5 Things to Know
Oil reserves, tariff investigations, airline fuel prices and more in Morning Squawk | This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.
Good morning. For those keeping track of layoff notices with AI mentions, add Atlassian to your list. The software company yesterday said it ... |
| 11.03.2026 | Google sells partial stake in fiber business, becomes minority owner of new venture | Google said its GFiber unit is combing with Astound Broadband and forming a independent fiber provider.
The new entity will be majority owned by investment firm Stonepeak.
“This partnership with Astound and Stonepeak is the next step in our... |
| 08.03.2026 | The Quiet Revolution: Foundational Innovation Reshapes Global Economies | Global innovation accelerates quietly. Deep tech, life sciences, and critical infrastructure drive the UK's $1.3 trillion economy. Foundations like quantum computing, AI platforms, and energy systems secure long-term value. Simultaneously, ... |
| 02.03.2026 | HSBC Innovation Banking CEO: the next phase of UK innovation will be won quietly | The next phase of UK innovation will be driven by deep tech, life sciences and infrastructure-heavy businesses, says Emily Turner
The UK’s innovation economy is now worth $1.3tn. Artificial intelligence sits at the heart of that story, comm... |
| 26.02.2026 | Revolut: Digital Powerhouse Redefines Global Finance Amidst Regulatory Scrutiny | Revolut, the UK fintech titan, achieved a $75 billion valuation in 2025, disrupting traditional banking. Global expansion remains a priority, marked by a Mexico banking launch. However, a full UK banking license still eludes the firm, amids... |
| 10.02.2026 | «Дочка» Alphabet представила ИИ-движок для дизайна лекарств — вдвое точнее AlphaFold 3 | Isomorphic Labs, дочерняя компания Alphabet и сестринская структура Google DeepMind, представила IsoDDE (Isomorphic Labs Drug Design Engine) — единый вычислительный движок для проектирования лекарственных молекул. На самом сложном бенчмарке... |
| 10.02.2026 | AI accelerates drug discovery from decades to months as Isomorphic Labs’ Drug Design Engine pushes beyond Nobel-Level science | In 2024, Sir Demis Hassabis and John Jumper were awarded the Nobel Prize in Chemistry for AlphaFold, an AI system that solved a fifty-year problem by predicting protein structures at scale.
The achievement felt like a finish line for AI-dri... |
| 06.02.2026 | From big rounds to broad momentum: the UK tech ecosystem | In 2025, the UK led European tech investment by a wide margin, raising €21.5 billion across 830 deals and topping investment volumes in every quarter of the year.
Funding was driven by a small number of very large transactions alongside a b... |
| 01.02.2026 | Europe's Tech Ascent: AI, Sovereignty, and Strategic Investments Redefine a Continent | European tech investment surged in 2025. It reached €72 billion. AI and infrastructure fueled this growth. The market matured, favoring larger, strategic, late-stage deals. Mistral AI, a key player, launched Vibe 2.0. Its open-source, on-pr... |
| 29.01.2026 | CB Insights Report: Digital Health Funding Hits $22.3B as 14 New Unicorns Emerge | What You Should Know
The Rebound: According to the new State of Digital Health 2025 report from CB Insights, digital health funding rose 19% YoY to $22.3B in 2025, driven by fewer, larger checks—average deal size jumped 29% to $20.3M.
The C... |
| 27.01.2026 | OpenAI’s real IP play: Why structural dependency, not your prompts, is the target | OpenAI is shifting its focus from monetising everyday ChatGPT prompts to building structural dependency through enterprise partnerships and “value sharing” on major commercial breakthroughs , says Paul Armstrong
UK businesses are asking the... |
| 25.01.2026 | London's King's Cross: A Global Powerhouse Emerges | London's King's Cross has transformed into a global innovation and retail powerhouse. Once a neglected area, it now thrives as a leading tech and life sciences hub, attracting major investment and creating high-value jobs. Retail sales show... |
| 20.01.2026 | Kings Cross spinout district could create 20,000 new jobs | The innovation district around Kings Cross and Euston has the potential to grow into the UK’s version of Kendall Square, writes Professor Geraint Rees
A smiling Oscar Murphy, 28, was all over the news this week. Oscar had become the first p... |
| 15.01.2026 | The 25 tech companies that dominated European funding in 2025 | According to the Tech.eu 2025 Annual Report, European technology companies raised €72 billion in 2025, making it the second-strongest year of the past three for tech investment. With more than 3,740 deals completed, investor activity remain... |
| 15.01.2026 | UK VC Investment Rebounds in 2025 | UK startups and scaleups raised $23.6 billion in venture capital funding in 2025, a 35% increase on 2024 and the first annual growth in UK VC investment in four years, according to new analysis from HSBC Innovation Banking UK and Dealroom.
... |
| 08.01.2026 | French BioTech Spore.Bio secures multi-million-euro Google.org funding and launches AI-native research unit | Paris-based Spore.Bio, a BioTech startup developing AI-based microbiology testing technology, today announced that it has secured multi-million-euro funding from the Google.Org Fund for AI in Science. Additionally, it has also launched Spor... |
| 03.01.2026 | Европейские венчурные инвестиции выросли в 2025 году — PitchBook | После трёх лет подряд снижения венчурного финансирования европейские стартапы демонстрируют признаки восстановления, однако это восстановление остаётся неравномерным в разных частях континента.
Согласно прогнозам PitchBook, объём венчурных ... |
| 31.12.2025 | ИИтоги 2025 года | Весь год я ежедневно следил за новостями в области искусственного интеллекта. И очень устал. Имена новых моделей, бьющих очередные бенчмарки, превращаются в шум, а мозг уже не реагирует на очередные срочные (!) сообщения инфлюэнсеров о БЕЗУ... |
| 06.11.2025 | Record breakers: Europe’s top 10 AI funding rounds of 2025 | We all know that artificial intelligence has moved beyond the hype phase and is now reshaping nearly every industry, from healthcare and finance to logistics, retail, and defence. Across Europe, this technology is here to stay, with billion... |
| 15.09.2025 | Europe's VC Shift: UK Fights for Lead as Healthtech Soars in 2025 | European venture capital is undergoing significant shifts in 2025. The UK remains a leader, but emerging competition from Germany and France is notable. Healthtech and AI innovation are major investment drivers, securing billions across the... |
| 11.09.2025 | Europe's 10 biggest healthtech deals in H1 2025 | Healthtech continued to demonstrate its strength in Europe in the first half of 2025, attracting €4 billion in funding, around 12 per cent of the €33.7 billion raised across all European tech sectors. Although healthtech accounted for just ... |
| 11.09.2025 | UK Venture Capital Market Performance 2025 | UK venture capital reached £4.1 billion across 507 deals in Q1 2025, maintaining European leadership despite a modest decline from £4.4 billion in Q4 2024.
x
Please enable JavaScript
Video Player is loading.Play Video
Play
Unmute
1xPlayback... |
| 21.08.2025 | European Venture Capital Valuations Climb in Q2 2025 Amid Market Uncertainty : Research | The European venture capital market has shown resilience in the second quarter of 2025, with valuations and deal sizes rising across most series despite ongoing geopolitical turbulence and macroeconomic uncertainty.
According to PitchBook’s... |
| 09.07.2025 | Europe’s AI Wave Has Sparked a Tech Funding Rebound | European tech funding has reached new heights, fuelled by a surge of AI-led innovation that has seen a recovery in megarounds and an acceleration in unicorn creation, according to a new report from GP Bullhound.
The tech advisory and invest... |
| 03.07.2025 | UK raises more H1 VC funding than Germany and France combined, new data reveals | UK startups raised more than $8bn in VC investments in the first half of this year, more than double that of French startups, as the AI investment mania continues, new figures show.
As London and Paris thrash it out for European startup pre... |
| 03.07.2025 | UK VC investment storms ahead of Europe as AI dominates | UK venture capital funding stormed ahead of its European peers in the first half of 2025 as the country’s innovation economy remained resilient in the face of wider geopolitical tensions.
Total investment topped $8bn (£5.9bn), edging up thr... |
| 03.07.2025 | AI Drives Record Share of UK VC Investment in 2025 | UK AI startups secured a record-breaking $2.4 billion (£1.7bn) in venture capital during the first half of 2025, accounting for 30% of all UK VC investment, an all-time high, according to fresh analysis from HSBC Innovation Banking UK and D... |
| 23.04.2025 | The Surge of Innovation: Healthtech and Energy Solutions in Europe | In the heart of Europe, a financial storm is brewing. The healthtech and AI sectors are not just weathering the global economic climate; they are thriving. In the first quarter of 2025, European healthtech and AI startups raised a staggerin... |
| 22.04.2025 | Europe’s healthtech and AI startups raise $13.9B in Q1 as global investors return | Q1 data from Dealroom reveals that European health tech and AI companies continue to attract significant interest from global venture capital investors, with $13.9 billion raised in the first quarter of 2025.
This represents a 2 per cent ye... |
| 18.04.2025 | The AI Surge: Europe's Beacon Amidst Economic Storms | In the tumultuous sea of European startups, artificial intelligence (AI) stands as a lighthouse. While other sectors struggle, AI shines brightly, attracting investment like moths to a flame. Recent data reveals a stark contrast: total tech... |
| 17.04.2025 | The AI Revolution: Transforming Tax Preparation and Venture Capital | The landscape of tax preparation is shifting. A new partnership between OpenAI and H&R Block is set to redefine how tax professionals operate. This collaboration aims to harness the power of generative AI to streamline the tax filing pr... |
| 17.04.2025 | London startups bag £2.69bn in VC funding in 2025 so far | London-based startups attracted £2.69bn in venture capital (VC) in the first three months of the year, marking a robust start of the year despite a fall in deal volumes.
According to KPMG’s latest venture pulse report, while deal count drop... |
| 17.04.2025 | AI keeps the lights on: European startups double down on AI as funding declines elsewhere | Despite growing concerns around declining investment levels across the European startup ecosystem, a fresh wave of data highlights one sector that continues to defy gravity—artificial intelligence.
This article draws on three recent studies... |
| 16.04.2025 | VC Investment Surges in Q1 2025, Driven by AI | Global VC investment surged from $118.7 billion in Q4’24 to a ten-quarter high of $126.3 billion in Q1’25, despite ongoing geopolitical conflicts and tensions, continued concerns about global trade and tariffs, and the delay of a major reop... |
| 14.04.2025 | Health Tech Leads UK VC Investment in 2025 Q1 | UK health tech and life sciences startups raised $1.8 billion in venture capital investment in Q1 2025, the sector’s second strongest quarter on record, according to new analysis from HSBC Innovation Banking UK and Dealroom.
Health was the ... |
| 14.04.2025 | UK surges ahead of France and Germany as Europe’s ‘innovation powerhouse’ | HSBC Innovation Banking, a subsidiary of Europe’s biggest lender, hailed the UK’s enterprise value in its latest innovation report.
UK innovation firms raised £3.2bn of venture capital in the first three months of the year – an eight per ce... |
| 09.04.2025 | Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind | Isomorphic Labs was spun out of Google DeepMind, after the tech giant achieved one of the biggest biological breakthroughs in the last 50 years.
Demis Hassabis is at the helm of both Isomorphic and DeepMind, the Google division at the foref... |
| 04.04.2025 | SandboxAQ Adds $150M From Google, Nvidia And Others | 0 Shares Email Facebook Twitter LinkedIn
Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes of Google and Nvidia.
The add-on comes less than four months after the com... |
| 04.04.2025 | €51.5M for material recycling, EVs outpace Tesla models and tariffs scare Europe's investors | This week we tracked more than 75 tech funding deals worth over €1.4 billion, and over 10 exits, M&A transactions, rumours, and related news stories across Europe.In addition to this week's top financials, we've also indexed the most im... |
| 04.04.2025 | March 2025's top 10 European tech deals you need to know about | According to the Tech.eu database, European tech companies secured €5.7 billion in funding in March 2025. Although the number of deals dropped by around 30 per cent compared to the same period in 2024, the total funds raised remained steady... |
| 31.03.2025 | Isomorphic Labs secures $600M in funding for AI drug design | Photo: Hero Images/Getty images
Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round.
Thrive Capital led the round, with participation from GV (Google Ventures) and existin... |
| 31.03.2025 | Google-backed AI drug discovery startup Isomorphic Labs raises $600 million in first funding round | Isomorphic Labs, a drug discovery startup spun out of Google DeepMind, just announced it has raised $600 million in its first round of external funding. The raise was led by Thrive Capital, with participation from Google Ventures and Alphab... |
| 31.03.2025 | Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provi... | Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round.
OpenAI backer Thrive Capital led the investment. It was joined by Alphabet and GV, the searc... |
| 31.03.2025 | Alphabet-Backed Isomorphic Labs Raises $600M For AI Drug Development | 3 Shares Email Facebook Twitter LinkedIn
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply artificial intelligence to the drug development process.
The new round was led by ... |
| 31.03.2025 | Isomorphic Labs nets $600M in first external funding round | A UK startup spun out of Google DeepMind focusing on leveraging AI to help drug discovery has raised $600 million, marking its first external funding round.
The funding round in Isomorphic Labs was led by Open AI-backer Thrive Capital with ... |
| 31.03.2025 | Isomorphic Labs Raises $600M in Funding | Isomorphic Labs, a London, UK-based AI-first drug design and development company, raised $600M in funding.
The round was led by Thrive Capital, with participation from GV, and existing investor Alphabet.
The company intends to use the funds... |
| 18.03.2025 | UPDATE -- NVIDIA, Alphabet and Google Collaborate on the Future of Agentic and Physical AI | SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- GTC -- Building on their longstanding partnership, NVIDIA, Alphabet and Google today announced new initiatives to advance AI, democratize access to AI tools, speed the development of phys... |
| 11.11.2024 | Google DeepMind open-sources AlphaFold 3, ushering in a new era for drug discovery and molecular biology | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use, mark... |
| 23.09.2024 | Google CEO Sundar Pichai Says AI Will Advance Humanity in These 4 Key Ways Pichai said studies show that AI could boost global labor productivity by 1.4 percentage points and increase global GDP by 7 ... |
This article originally appeared on Business Insider.
Big Tech companies like Google are betting that AI technology will help them earn billions in profits, and they're funneling tons of resources toward the technology.
But this rush to ca... |
| 08.05.2024 | Google’s AlphaFold 3 AI predicts the very building blocks of life | Join us in returning to NYC on June 5th to collaborate with executive leaders in exploring comprehensive methods for auditing AI models regarding bias, performance, and ethical compliance across diverse organizations. Find out how you can a... |
| 08.05.2024 | Google Unveils AI-Powered Molecular Structure Predictor With Unprecedented Accuracy | Aldohn Domingo, Tech Times 08 May 2024, 10:05 pm
Google's new artificial intelligence model, AlphaFold 3, is the latest AI-centered medical breakthrough. It can reportedly help create new drug designs, crops, medical treatments, and genomic... |
| 08.01.2024 | Alphabet’s AI-driven drug discovery startup Isomorphic lands $3 billion pharma deals with Lilly and Novartis | Alphabet’s Isomorphic, an AI-driven drug discovery startup, has scored two major deals from pharmaceutical giants Eli Lilly and Novartis, ringing in at nearly $3 billion combined. These deals will notably bolster Google DeepMind’s AlphaFold... |
| 08.01.2024 | AI-driven drug discovery is poised to boom in 2024 | The AI Beat | Join leaders in San Francisco on January 10 for an exclusive night of networking, insights, and conversation. Request an invite here.
AI-driven drug discovery is about to boom in 2024, if the fast and furious pace of announcements timed to ... |
| 27.07.2023 | A year ago, DeepMind’s AlphaFold AI changed the shape of science — but there is more work to do | Head over to our on-demand library to view sessions from VB Transform 2023. Register Here
OpenAI’s ChatGPT may have captured the AI zeitgeist last fall, but it was DeepMind’s AlphaFold AI that shook the science world last summer.
A year ago... |
| 28.02.2023 | How an AI breakthrough from Alphabet's DeepMind 'changed scientific history' and could lead to new cures | Researchers at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia use DeepMind's AlphaFold 2 technology to predict protein structures while researching Parkinson's disease. DeepMind This story is available exclu... |
| 05.11.2021 | Pierre Beaurang hits the ground running at his 3rd startup; Mike Grey poaches Astellas dealmaker to head protein degradation player | Pierre Beaurang
As Nitrome Biosciences — a biotech founded in 2017 to focus on a class of enzymes called nitrases — rebrands to Nitrase Therapeutics, the company is also bringing on a new CEO: Pierre Beaurang.
In Nitrase’s... |
| 05.11.2021 | Covid-19 roundup: Novavax's manufacturing woes nearing an end?; FDA rejects coronavirus drug in NIH trial | The US government’s $1.8 billion investment into Novavax’s Covid-19 vaccine may soon pay off as the company floated some positive comments around the issues surrounding the manufacturing of its recombinant protein v... |
| 05.11.2021 | Cell therapy startup bit.bio adds $100M+ to its coffers and some impressive names to its board of directors | Bit.bio CEO Mark Kotter says the last major revolution in biopharma occurred around the 1980s, when antibodies — or, as some called them, anticancer “magic bullets” — opened up the door for new therapies.
Now cell therapy... |
| 05.11.2021 | Google’s Alphabet jumps into the drug business with the launch of Isomorphic Labs, an AI-driven drug discovery startup | The global pharmaceutical manufacturing market size was valued at $405.52 billion in 2020 and is expected to grow at a compound annual growth rate of 11.34% from 2021 to 2028. Thanks to covid vaccines, pharmaceutical companies like Pfizer, ... |
| 05.11.2021 | Alphabet launches new company to use AI for drug research | Team TC 5 Nov, 2021
Google's parent company Alphabet has created a new company called Isomorphic Labs to leverage artificial intelligence (AI) for medical research and drug discovery.
Alphabet's AI company DeepMind has already made some inr... |
| 05.11.2021 | A pair of European biotechs hit below their mark as close of 2021 biotech IPO market chugs a little bit slower | Say hello to yet two more biotechs that jumped on a 2021 IPO this week.
German firm Evotec SE debuted a downsized IPO in the US yesterday — pricing at $21.75 per ADS share and $43.50 for a share on Nasdaq under the ticker $EVO.
Th... |
| 05.11.2021 | San Fran biotech gets another blow to lead drug; Swiss biotech raises $49 million in Series A — with help from big venture | In the wake of Calithera Biosciences axing a third of its workforce in January over a failed Phase II trial with lead drug telaglenastat in patients with renal cell carcinoma, they just got slammed with the second half of a ... |
| 04.11.2021 | Isomorphic Labs is Alphabet’s play in AI drug discovery | The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information problem. The latest to do so is Google pare... |
| 04.11.2021 | Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs | Moderna has drawn plaudits from around the industry and the globe for its Covid-19 vaccine, and it reported continued financial success Thursday in its third-quarter report. But the biotech also quietly announced the discontinuation of anot... |
| 04.11.2021 | More than a year after trimming R&D unit, Ironwood adds a rare disease drug to the pipeline in hopeful step forward | Ironwood Pharmaceuticals has walked a less-than-easy path the past few years with a proxy-driven shakeup and multiple clinical failures rocking the company. Now under new leadership, Ironwood is snagging rights to a rare... |
| 04.11.2021 | PlateletBio announces $75.5M Series B to extend autoimmune cell therapy | More than two years after PlateletBio landed its first round of fundraising and a contract with the US government, the company announced its Series B round Thursday.
The preclinical stage biotech out of Watertown, MA annou... |
| 04.11.2021 | Lonza enters the exosome therapy space with acquisition of still-new Codiak site | In anticipation of tackling the manufacturing problems that come with exosome therapeutics head on, Codiak BioSciences built a 12,000-square-foot manufacturing site in Lexington, MA. Tuesday, it announced that it w... |
